TherapeuticsMD, Inc. (NYSE: TXMD) is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to help enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. TherapeuticsMD also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the vitaMedMD and BocaGreenMD brands. For more information, visit the company’s website at www.therapeuticsmd.com